Skip to content

Paul M. Meister

CEO & Founding Partner - Liberty Lane Partners, LLC.

Mr. Meister is co-founder of Liberty Lane Partners, LLC, a private investment company founded in 2007. He is an investor directly or through Liberty Lane Partners, LLC in biotechnology, healthcare, technology, and distribution-related industries. He is also co-founder of Perspecta Trust, a trust company that provides trust and investment services.

Mr. Meister served as President of MacAndrews & Forbes Incorporated from 2014-2018. He was Chairman and CEO of inVentiv Health (now Syneos Health), a leading provider of commercial, consulting, and clinical research services to the pharmaceutical and biotech industries from 2010-2014.

Previously, Mr. Meister served as Chairman of the Board of Thermo Fisher Scientific, Inc. and Vice Chairman of Fisher Scientific International, Inc. prior to Fisher’s merger with Thermo.

During Mr. Meister’s tenure as an executive officer of Fisher Scientific, from 1991 to 2006, the company’s revenue and operating income grew at a compound annual growth rate of 15% and 23% respectively as operations grew from two countries to 27 and sales expanded into 140 countries worldwide.

Earlier in his career, Mr. Meister served in a number of executive leadership positions at Wheelabrator Technologies Inc., The Henley Group Inc., and AlliedSignal Inc. (now Honeywell International, Inc.). He began his career with Ford Motor Company. Mr. Meister holds a Bachelor of Arts degree from the University of Michigan and an MBA from Northwestern University. He is a director of the following public companies; Aptiv PLC, Oaktree Acquisitions Corporation, Amneal Pharmaceuticals, Inc. and, Quanterix Corporation. He is co-chair of the University of Michigan’s Life Sciences Institute External Advisory Board and chair of the Provost’s Advisory Board and serves on the board of New York Stem Cell Foundation.

Back to Leadership

We use our own and third-party cookies to personalize content and to analyze web traffic.

Read our privacy policy